Does vaping increase the likelihood of SARS-CoV-2 infection? Paradoxically yes and no

被引:7
|
作者
Phandthong, Rattapol [1 ]
Wong, Man [1 ]
Song, Ann [1 ]
Martinez, Teresa [1 ]
Talbot, Prue [1 ]
机构
[1] Univ Calif Riverside, Dept Mol Cell & Syst Biol, Riverside, CA 92521 USA
关键词
ACE2; COVID-19; electronic cigarettes; SARS-CoV-2; TMPRSS2; CELL ENTRY; SMOKING; BASAL; ACE2;
D O I
10.1152/ajplung.00300.2022
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Data on the relationship between electronic cigarettes (ECs) and SARS-CoV-2 infection are limited and contradictory. Our objectives were to investigate the impact of EC aerosols on SARS-CoV-2 infection of human bronchial epithelial cells and identify the causative chemical(s). Fully differentiated human bronchial epithelial tissues (hBETs) were exposed at the air-liquid interface (ALI) to aerosols produced from JUUL "Virginia Tobacco" and BLU ECs, as well as nicotine, propylene glycol (PG), vegetable glycerin (VG), and benzoic acid, and infection was then evaluated with SARS-CoV-2 pseudoparticles. Pseudoparticle infection of hBETs increased with aerosols produced from PG/VG, PG/VG plus nicotine, or BLU ECs; however, JUUL EC aerosols did not increase infection compared with controls. Increased infection in PG/VG alone was due to enhanced endocytosis, whereas increased infection in PG/VG plus nicotine or in BLU ECs was caused by nicotine-induced elevation of the aerosol's pH, which correlated with increased transmembrane protease, serine 2 (TMPRSS2) activity. Notably, benzoic acid in JUUL aerosols mitigated the enhanced infection caused by PG/VG or nicotine, offering protection that lasted for at least 48 h after exposure. In conclusion, the study demonstrates that EC aerosols can impact susceptibility to SARS-CoV-2 infection depending on their specific ingredients. PG/VG alone or PG/VG plus nicotine enhanced infection through different mechanisms, whereas benzoic acid in JUUL aerosols mitigated the increased infection caused by certain ingredients. These findings highlight the complex relationship between ECs and SARS-CoV-2 susceptibility, emphasizing the importance of considering the specific aerosol ingredients when evaluating the potential effects of ECs on infection risk. NEW & NOTEWORTHY Data on the relationship between electronic cigarettes (ECs) and SARS-CoV-2 infection are limited and contradictory. We investigated the impact of EC aerosols and their ingredients on SARS-CoV-2 infection of human bronchial epithelial cells. Our data show that specific ingredients in EC aerosols impact the susceptibility to SARS-CoV-2 infection. Propylene glycol (PG)/vegetable glycerin (VG) alone or PG/VG plus nicotine enhanced infection through different mechanisms, whereas benzoic acid in JUUL aerosols mitigated the increased infection caused by these ingredients.
引用
收藏
页码:L175 / L189
页数:15
相关论文
共 50 条
  • [41] Immunology of SARS-CoV-2 Infection
    Gabdoulkhakova A.G.
    Mingaleeva R.N.
    Romozanova A.M.
    Sagdeeva A.R.
    Filina Y.V.
    Rizvanov A.A.
    Miftakhova R.R.
    Biochemistry (Moscow), 2024, 89 (1) : 65 - 83
  • [42] The neurobiology of SARS-CoV-2 infection
    Jenny Meinhardt
    Simon Streit
    Carsten Dittmayer
    Regina v. Manitius
    Helena Radbruch
    Frank L. Heppner
    Nature Reviews Neuroscience, 2024, 25 : 30 - 42
  • [43] Infection of dogs with SARS-CoV-2
    Thomas H. C. Sit
    Christopher J. Brackman
    Sin Ming Ip
    Karina W. S. Tam
    Pierra Y. T. Law
    Esther M. W. To
    Veronica Y. T. Yu
    Leslie D. Sims
    Dominic N. C. Tsang
    Daniel K. W. Chu
    Ranawaka A. P. M. Perera
    Leo L. M. Poon
    Malik Peiris
    Nature, 2020, 586 : 776 - 778
  • [44] Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study
    Alhousseini, Ali
    Turkoglu, Onur
    Sajja, Sonia
    Wharton, Kurt
    Idler, Jay
    Bahado-Singh, Ray
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2022, 87 (3-4) : 219 - 225
  • [45] Does a previous SARS-CoV-2 Infection protect against re-infection?
    Metzger, Leandra
    PNEUMOLOGIE, 2022, 76 (08): : 524 - 524
  • [46] Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection
    Kirtsman, Maksim
    Diambomba, Yenge
    Poutanen, Susan M.
    Malinowski, Ann K.
    Vlachodimitropoulou, Evangelia
    Parks, W. Tony
    Erdman, Laura
    Morris, Shaun K.
    Shah, Prakesh S.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (24) : E647 - E650
  • [47] SARS-CoV-2 Placentitis: An Increasingly Recognised Complication of Maternal SARS-CoV-2 Infection
    Ciolka, B.
    Simmons, W.
    McPartland, J.
    Hurrell, D.
    Shukla, R.
    JOURNAL OF PATHOLOGY, 2021, 255 : S39 - S39
  • [48] Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
    Zouaki, Amal
    Kabbaj, Hakima
    El Amin, Ghizlane
    Ouadghiri, Mouna
    Belefquih, Bouchra
    Ibrahimi, Azeddine
    Seffar, Myriam
    ADVANCES IN VIROLOGY, 2023, 2023
  • [49] Vaping, SARS-CoV-2, and Multisystem Inflammatory Syndrome: A Perfect Storm
    Brar, Esha
    Saxena, Anish
    Dukler, Claudia
    Xu, Fangxi
    Saxena, Deepak
    Cheema Brar, Preneet
    Guo, Yuqi
    Li, Xin
    FRONTIERS IN PEDIATRICS, 2021, 9
  • [50] Does peripartum SARS-CoV-2 Infection change maternal and fetal Outcomes?
    Ruchalla, Elke
    ANASTHESIOLOGIE INTENSIVMEDIZIN NOTFALLMEDIZIN SCHMERZTHERAPIE, 2022, 57 (03): : 166 - 167